共 35 条
Gastric peroral endoscopic pyloromyotomy versus gastric electrical stimulation in the treatment of refractory gastroparesis: a propensity score-matched analysis of long term outcomes
被引:51
作者:
Shen, Shanshan
[1
,2
]
Luo, Hui
[1
,3
,4
]
Vachaparambil, Cicily
[1
]
Mekaroonkamol, Parit
[1
,5
,6
]
Magdy, Mohamed
[1
]
Xu, Guifang
[1
,2
]
Chen, Huimin
[1
,7
]
Xia, Liang
[1
,8
]
Shi, Hong
[1
,9
]
Keilin, Steve
[1
]
Willingham, Field
[1
]
Christie, Jennifer
[1
]
Lin, Edward
[1
]
Cai, Qiang
[1
]
机构:
[1] Emory Univ, Sch Med, Div Digest Dis, 1365 Clifton Rd,B1262, Atlanta, GA 30322 USA
[2] Nanjing Univ, Med Sch, Dept Gastroenterol, Nanjing Drum Tower Hosp,Affiliated Hosp, Nanjing, Jiangsu, Peoples R China
[3] Fourth Mil Med Univ, Natl Clin Res Ctr Digest Dis, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China
[4] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian, Shaanxi, Peoples R China
[5] Chulalongkorn Univ, Fac Med, Div Gastroenterol, Bangkok, Thailand
[6] King Chulalongkorn Mem Hosp, Thai Red Cross, Bangkok, Thailand
[7] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Div Gastroenterol & Hepatol, Shanghai, Peoples R China
[8] Nanchang Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanchang, Jiangxi, Peoples R China
[9] Fujian Med Univ, Canc Hosp, Fujian Canc Hosp, Dept Gastrointestinal Endoscopy, Fuzhou, Fujian, Peoples R China
来源:
关键词:
QUALITY-OF-LIFE;
DIABETIC GASTROPARESIS;
SYMPTOMATIC RESPONSE;
BOTULINUM-TOXIN;
FOLLOW-UP;
EXPERIENCE;
MANAGEMENT;
MYOTOMY;
D O I:
10.1055/a-1111-8566
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
Background Gastric peroral endoscopic pyloromyotomy (G-POEM) and gastric electrical stimulation (GES) have been reported as treatment options for refractory gastroparesis. In this study, we compared the long term clinical outcomes of G-POEM versus GES in the treatment of such patients. Methods We retrospectively evaluated 111 consecutive patients with refractory gastroparesis between January 2009 and August 2018. To overcome selection bias, we used propensity score matching (1:1) between G-POEM and GES treatment. The primary outcome was the duration of clinical response. Results After propensity score matching, 23 patients were included in each group. After a median follow-up of 27.7 months, G-POEM had a significantly better and longer clinical response than GES (hazard ratio [HR] for clinical recurrence 0.39, 95 % confidence interval [CI] 0.16 - 0.95; P = 0.04). The median duration of response was 25.4 months (95 %CI 8.7 - 42.0) in the GES group and was not reached in the G-POEM group. The Kaplan - Meier estimate of 24-month clinical response rate was 76.6 % with G-POEM vs. 53.7 % with GES. GES appeared to have little effect on idiopathic gastroparesis (HR for recurrence with G-POEM vs. GES 0.35, 95 %CI 0.13 - 0.95; P = 0.05). The incidence of adverse events was higher in the GES group (26.1 % vs. 4.3 %; P = 0.10). Conclusion Among patients with refractory gastroparesis, clinical response was better and lasted longer with G-POEM than with GES. The positive outcomes with G-POEM are likely to derive from the superior clinical response in patients with idiopathic gastroparesis. Further studies are needed to confirm these findings.
引用
收藏
页码:349 / 358
页数:10
相关论文